# OLD MARKET CAPITAL Corp: financial statements, quarterly

OMCC · OTC · CIK 1000045 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/omcc.md) · [Financials](/companies/omcc/financials.md) · [Filings](/companies/omcc/filings.md) · [Insiders](/companies/omcc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/omcc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2022-12-31) | Q4 FY2023 (2023-03-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [11.3](/filings/0000950170-23-002704.md) | [8.7 d](/filings/0000950170-23-030037.md) | [0.0](/filings/0000950170-24-100547.md) | [0.0](/filings/0000950170-24-126356.md) | [0.0](/filings/0000950170-25-021128.md) | [0.0 d](/filings/0000950170-25-091151.md) | [0.5](/filings/0000950170-25-108819.md) | [3.0](/filings/0000950170-24-126356.md) | [3.0](/filings/0000950170-25-021128.md) | [3.0 d](/filings/0000950170-25-091151.md) | [3.0](/filings/0000950170-25-108819.md) | [3.2](/filings/0001437749-25-035199.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | [(1.5)](/filings/0000950170-24-100547.md) | [(1.6)](/filings/0000950170-24-126356.md) | [(1.8)](/filings/0000950170-25-021128.md) | [(1.4) d](/filings/0000950170-25-091151.md) | [(3.6)](/filings/0000950170-25-108819.md) | [(1.3)](/filings/0001437749-25-035199.md) | [(0.7)](/filings/0000950170-25-021128.md) | [(1.4) d](/filings/0000950170-25-091151.md) | [(1.0)](/filings/0000950170-25-108819.md) | [(1.0)](/filings/0001437749-25-035199.md) |
| Interest expense | $m | [1.2](/filings/0000950170-24-014566.md) | [1.1 d](/filings/0000950170-24-079650.md) | [0.5](/filings/0000950170-23-043019.md) | [0.3](/filings/0000950170-23-063651.md) | [0.1](/filings/0000950170-24-014566.md) | [0.1 d](/filings/0000950170-24-079650.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.0](/filings/0000950170-24-014566.md) | [0.0 d](/filings/0000950170-24-079650.md) | [0.0](/filings/0000950170-24-100547.md) | [0.0](/filings/0000950170-24-126356.md) | [0.0](/filings/0000950170-25-021128.md) | [0.0 d](/filings/0000950170-25-091151.md) | [(0.1)](/filings/0000950170-25-108819.md) | [0.1](/filings/0001437749-25-035199.md) | [0.1](/filings/0000950170-25-021128.md) | [0.0 d](/filings/0000950170-25-091151.md) | [0.0](/filings/0000950170-25-108819.md) | [0.0](/filings/0001437749-25-035199.md) |
| Net income | $m | [(13.4)](/filings/0000950170-24-014566.md) | [(15.8) d](/filings/0000950170-24-079650.md) | [1.6](/filings/0000950170-24-100547.md) | [(10.5)](/filings/0000950170-24-126356.md) | [(11.7)](/filings/0000950170-25-021128.md) | [(0.2) d](/filings/0000950170-25-091151.md) | [(3.3)](/filings/0000950170-25-108819.md) | [(0.7)](/filings/0001437749-25-035199.md) | [(0.2)](/filings/0000950170-25-021128.md) | [(1.0) d](/filings/0000950170-25-091151.md) | [(0.7)](/filings/0000950170-25-108819.md) | [(0.8)](/filings/0001437749-25-035199.md) |
| Diluted EPS | $ per share | [(1.85)](/filings/0000950170-24-014566.md) | not reported | [0.21](/filings/0000950170-24-100547.md) | [(1.44)](/filings/0000950170-24-126356.md) | [(1.60)](/filings/0000950170-25-021128.md) | not reported | [(0.49)](/filings/0000950170-25-108819.md) | [(0.10)](/filings/0001437749-25-035199.md) | [(0.04)](/filings/0000950170-25-021128.md) | not reported | [(0.11)](/filings/0000950170-25-108819.md) | [(0.11)](/filings/0001437749-25-035199.md) |
| Basic EPS | $ per share | [(1.85)](/filings/0000950170-24-014566.md) | not reported | [0.21](/filings/0000950170-24-100547.md) | [(1.44)](/filings/0000950170-24-126356.md) | [(1.60)](/filings/0000950170-25-021128.md) | not reported | [(0.49)](/filings/0000950170-25-108819.md) | [(0.10)](/filings/0001437749-25-035199.md) | [(0.04)](/filings/0000950170-25-021128.md) | not reported | [(0.11)](/filings/0000950170-25-108819.md) | [(0.11)](/filings/0001437749-25-035199.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2022-12-31) | FY2023 (2023-03-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.9](/filings/0000950170-23-002704.md) | [0.5](/filings/0000950170-25-091151.md) | [0.7](/filings/0000950170-23-043019.md) | [0.7](/filings/0000950170-23-063651.md) | [7.8](/filings/0000950170-25-021128.md) | [19.0](/filings/0001437749-25-035199.md) | [40.6](/filings/0000950170-25-108819.md) | [29.5](/filings/0001437749-25-035199.md) | [27.1](/filings/0000950170-25-021128.md) | [24.5](/filings/0001437749-25-035199.md) | [22.0](/filings/0000950170-25-108819.md) | [18.9](/filings/0001437749-25-035199.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | [59.7](/filings/0000950170-25-091151.md) | [42.6](/filings/0000950170-24-100547.md) | [32.5](/filings/0000950170-24-126356.md) | [30.5](/filings/0000950170-25-021128.md) | [27.4](/filings/0001437749-25-035199.md) | [25.4](/filings/0000950170-25-108819.md) | [22.6](/filings/0001437749-25-035199.md) |
| Total assets | $m | [145](/filings/0000950170-23-002704.md) | [110](/filings/0000950170-24-079650.md) | [98.1](/filings/0000950170-23-043019.md) | [75.8](/filings/0000950170-23-063651.md) | [60.0](/filings/0000950170-24-014566.md) | [59.8](/filings/0000950170-25-091151.md) | [88.7](/filings/0000950170-24-100547.md) | [80.3](/filings/0000950170-24-126356.md) | [79.5](/filings/0000950170-25-021128.md) | [77.7](/filings/0001437749-25-035199.md) | [78.9](/filings/0000950170-25-108819.md) | [81.1](/filings/0001437749-25-035199.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | [0.9](/filings/0000950170-25-091151.md) | [11.5](/filings/0000950170-24-100547.md) | [3.2](/filings/0000950170-24-126356.md) | [3.1](/filings/0000950170-25-021128.md) | [2.9](/filings/0001437749-25-035199.md) | [4.0](/filings/0000950170-25-108819.md) | [5.0](/filings/0001437749-25-035199.md) |
| Total liabilities | $m | [49.6](/filings/0000950170-23-002704.md) | [30.5](/filings/0000950170-24-079650.md) | [16.9](/filings/0000950170-23-043019.md) | [5.1](/filings/0000950170-23-063651.md) | [0.9](/filings/0000950170-24-014566.md) | [1.0](/filings/0000950170-25-091151.md) | [16.6](/filings/0000950170-24-100547.md) | [8.3](/filings/0000950170-24-126356.md) | [11.3](/filings/0000950170-25-021128.md) | [10.7](/filings/0001437749-25-035199.md) | [12.6](/filings/0000950170-25-108819.md) | [15.2](/filings/0001437749-25-035199.md) |
| Long-term debt | $m | [44.6](/filings/0000950170-23-002704.md) | [28.9](/filings/0000950170-23-030037.md) | not reported | not reported | not reported | [0.0](/filings/0000950170-25-091151.md) | not reported | not reported | [0.8](/filings/0000950170-25-021128.md) | [0.8](/filings/0001437749-25-035199.md) | [1.6](/filings/0000950170-25-108819.md) | [3.3](/filings/0001437749-25-035199.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001437749-25-035199.md) | not reported | [0.1](/filings/0001437749-25-035199.md) |
| Shareholders' equity | $m | [95.6](/filings/0000950170-24-014566.md) | [79.8](/filings/0000950170-25-091151.md) | [81.2](/filings/0000950170-24-126356.md) | [70.7](/filings/0000950170-25-021128.md) | [59.1](/filings/0000950170-25-021128.md) | [58.8](/filings/0000950170-25-091151.md) | [53.1](/filings/0000950170-24-100547.md) | [52.7](/filings/0000950170-24-126356.md) | [53.9](/filings/0000950170-25-021128.md) | [53.1](/filings/0001437749-25-035199.md) | [52.5](/filings/0000950170-25-108819.md) | [53.8](/filings/0001437749-25-035199.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2022-12-31) | Q4 FY2023 (2023-03-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(551) d](/filings/0000950170-24-014566.md) | [(661) d](/filings/0000950170-24-079650.md) | [1,169](/filings/0000950170-24-100547.md) | [284 d](/filings/0000950170-24-126356.md) | [(418) d](/filings/0000950170-25-021128.md) | [792 d](/filings/0000950170-25-091151.md) | [(438)](/filings/0000950170-25-108819.md) | [(94.0) d](/filings/0001437749-25-035199.md) | [(613) d](/filings/0000950170-25-021128.md) | [(755) d](/filings/0000950170-25-091151.md) | [912](/filings/0000950170-25-108819.md) | [(133) d](/filings/0001437749-25-035199.md) |
| Capital expenditure | $k | [0.0 d](/filings/0000950170-24-014566.md) | [59.0 d](/filings/0000950170-24-079650.md) | [13.0](/filings/0000950170-24-100547.md) | [0.0 d](/filings/0000950170-24-126356.md) | [(13.0) d](/filings/0000950170-25-021128.md) | [0.0 d](/filings/0000950170-25-091151.md) | [369](/filings/0000950170-25-108819.md) | [3,571 d](/filings/0001437749-25-035199.md) | [2,288 d](/filings/0000950170-25-021128.md) | [2,188 d](/filings/0000950170-25-091151.md) | [3,731](/filings/0000950170-25-108819.md) | [4,771 d](/filings/0001437749-25-035199.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | [110 d](/filings/0000950170-24-014566.md) | [0.0 d](/filings/0000950170-24-079650.md) | [0.0](/filings/0000950170-23-043019.md) | [0.0 d](/filings/0000950170-23-063651.md) | [0.0 d](/filings/0000950170-24-014566.md) | [0.0 d](/filings/0000950170-24-079650.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2021-12-31) | Q1 FY2023 (2022-06-30) | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,621](/filings/0000950170-23-002704.md) | [7,464](/filings/0000950170-23-043019.md) | [7,273](/filings/0000950170-23-063651.md) | [7,219](/filings/0000950170-24-014566.md) | [7,289](/filings/0000950170-24-100547.md) | [7,286](/filings/0000950170-24-126356.md) | [7,296](/filings/0000950170-25-021128.md) | [6,754](/filings/0000950170-25-108819.md) | [6,659](/filings/0001437749-25-035199.md) | [6,690](/filings/0000950170-25-021128.md) | [6,754](/filings/0000950170-25-108819.md) | [6,754](/filings/0001437749-25-035199.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,790,097 at 2025-11-13, from the cover of the [10-Q filed 2025-11-14](/filings/0001437749-25-035199.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.